rs281875317
Variant summary
Our verdict is Pathogenic. Variant got 24 ACMG points: 24P and 0B. PS1_Very_StrongPM2PM5PP3_StrongPP5_Very_Strong
The ENST00000311597.10(MLC1):c.634G>C(p.Gly212Arg) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G212E) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000311597.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 24 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MLC1 | NM_015166.4 | c.634G>C | p.Gly212Arg | missense_variant | 8/12 | ENST00000311597.10 | NP_055981.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MLC1 | ENST00000311597.10 | c.634G>C | p.Gly212Arg | missense_variant | 8/12 | 1 | NM_015166.4 | ENSP00000310375 | P1 | |
MLC1 | ENST00000395876.6 | c.634G>C | p.Gly212Arg | missense_variant | 8/12 | 1 | ENSP00000379216 | P1 | ||
MLC1 | ENST00000442311.1 | c.544G>C | p.Gly182Arg | missense_variant | 7/8 | 5 | ENSP00000401385 | |||
MLC1 | ENST00000470008.1 | n.114G>C | non_coding_transcript_exon_variant | 2/3 | 3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Megalencephalic leukoencephalopathy with subcortical cysts 1 Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Aug 16, 2017 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Jan 30, 2023 | - - |
Megalencephalic leukoencephalopathy with subcortical cysts Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 07, 2024 | Variant summary: MLC1 c.634G>C (p.Gly212Arg) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 250780 control chromosomes. c.634G>C has been reported in the literature in at least one biallelic individual affected with Megalencephalic Leukoencephalopathy With Subcortical Cysts 1 (e.g. Duarri_2008). One publication reports experimental evidence evaluating an impact on protein function showing reduced expression of the MLC1 protein at the plasma membrane in vitro (e.g. Teijido_2004), however, does not allow convincing conclusions about the variant effect. A different variant resulting in the same amino acid change (c.634G>A, p.Gly212Arg) has been previously classified as Likely pathogenic by our lab. ClinVar contains an entry for this variant (Variation ID: 553381). Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at